The APT e-Guidelines cover the 2018 CCS/CAIC Guidelines for the Use of Antiplatelet Therapy Update. This update to the 2011 and 2013 Antiplatelet Therapy Guidelines incorporates new evidence on how to optimally use antiplatelet therapy, particularly in conditions which few to no data were previously available.1,2
The CCS gratefully acknowledges the generous volunteer contributions of the many primary and secondary panel members, organizations and individuals involved in the creation and dissemination of the APT Guidelines. Please see the APT Guideline Panel Members page for a complete list of the many volunteer panel members who have contributed to these guidelines.
Additional Guideline Tools and Resources
Additional guideline tools and resources including pocket guides, educational videos, slide decks and our very popular iCCS Guideline apps are available on the CCS website. Click the links below to learn more:
The CCS has developed specific policies and procedures to ensure that our guidelines are high quality and transparent. Guideline development is overseen by the CCS Guidelines Committee and guideline topic development is undertaken by a multidisciplinary panel of topic experts. CCS follows the AGREE II Instrument as an overarching methodology and has adopted the GRADE Scale for rating the strength of recommendations and the quality of evidence. For more information visit www.ccs.ca/en/guidelines/development-process
1. Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol 2011;27 Suppl A:S1-59.
2. Tanguay JF, Bell AD, Ackman ML, et al. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. Can J Cardiol 2013;29:1334-45.